Swander Pace Capital Announces First Continuation Fund with Captek Softgel International. Inc. in Partnership with Morgan Stanley and Rabo Investments
The new continuation fund acquired Captek from Swander Pace Capital Fund V and Swander Pace Capital Fund VI.
- The new continuation fund acquired Captek from Swander Pace Capital Fund V and Swander Pace Capital Fund VI.
- Morgan Stanley was the lead investor in the continuation fund and is joined by Rabo Investments, the investment arm of Rabobank, as well as Swander Pace reinvesting LPs and GPs.
- The new Fund includes substantial capital investment to drive organic growth initiatives and strategic acquisitions for Captek going forward.
- Swander Pace Capital acquired Captek in December of 2015 and later added onto this initial investment with the acquisition of J&D Labs in July of 2017.